Evidence map›Paper›PMID 26381868›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2015

Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.

Laura Weise-Cross, Joan M Taylor, Christopher P Mack

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Emerging regulators of vascular smooth muscle cell migration.Journal of muscle research and cell motility · 2019
    Review
  5. Vascular Development.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
  6. Article
  7. Vascular Smooth Muscle Cells.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laura Weise-CrossFrom the Department of Pathology, University of North Carolina, Chapel Hill.
Joan M TaylorFrom the Department of Pathology, University of North Carolina, Chapel Hill.
Christopher P MackFrom the Department of Pathology, University of North Carolina, Chapel Hill. cmack@med.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Genetic and epigenetic regulation of vascular smooth muscle cell phenotype and contractilityR01HL109607 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2012 to 2022
$3.0M
Regulation of Smooth Muscle Differentiation by RhoAR01HL070953 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2002 to 2012
$2.8M
Smooth muscle adhesion and plasticity in coronary and outflow tract developmentR01HL102446 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2010 to 2013
$1.3M
Molecular regulation of the myocardin factors in vascular smooth muscleR01HL082883 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2009 to 2010
$740k
NHLBI NIH HHS HL070953NHLBI NIH HHS HL102446NHLBI NIH HHS HL109607NHLBI NIH HHS R01 HL070953NHLBI NIH HHS R01 HL082883NHLBI NIH HHS R01 HL102446NHLBI NIH HHS R01 HL109607NHLBI NIH HHS T32 HL069768NHLBI NIH HHS T32HL069768
6 · The paper itself

Abstract

objectiveWe and others have previously shown that RhoA-dependent stimulation of myocardin-related transcription factor nuclear localization promotes smooth muscle cell (SMC) marker gene expression. The goal of this study was to provide direct in vivo evidence that actin polymerization by the diaphanous-related formins contributes to the regulation of SMC differentiation and phenotype. APPROACH AND

resultsConditional Cre-based genetic approaches were used to overexpress a well-characterized dominant-negative variant of mDia1 (DNmDia) in SMC. DNmDia expression in SM22-expressing cells resulted in embryonic and perinatal lethality in ≈20% of mice because of defects in myocardial development and SMC investment of peripheral vessels. Although most DNmDia(+)/SM22Cre(+) mice exhibited no overt phenotype, the re-expression of SMC differentiation marker gene expression that occurs after carotid artery ligation was delayed, and this effect was accompanied by a significant decrease in myocardin-related transcription factor-A nuclear localization. Interestingly, neointima growth was inhibited by expression of DNmDia in SMC and this was likely because of a defect in directional SMC migration and not to defects in SMC proliferation or survival. Finally, by using the tamoxifen-inducible SM MHC-CreER(T2) line, we showed that SMC-specific induction of DNmDia in adult mice decreased SMC marker gene expression.

conclusionsOur demonstration that diaphanous-related formin signaling plays a role in heart and vascular development and the maintenance of SMC phenotype provides important new evidence that Rho/actin/myocardin-related transcription factor signaling plays a critical role in cardiovascular function.

Indexed as

Signal TransductionActinsAnimalsCarotid ArteriesCarotid Artery InjuriesCarrier ProteinsCell DifferentiationCell LineCell MovementCell ProliferationDisease Models, AnimalForminsHeartHeart Defects, CongenitalLigationMice, TransgenicActinsCarrier ProteinsDiap1 protein, mouseForminsMicrofilament ProteinsMuscle ProteinsTagln protein, mousecarotid arteriesmDia2 proteinmousemyocardinphenotypesmooth muscle

Identifiers

PMID26381868
PMCPMC5540365
OpenAlexW1919713619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.